Loading ...

polymethyloxazoline-polydimethylsiloxane nanomembrane

Based on

1 Articles
2008 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

polymethyloxazoline-polydimethylsiloxane-polymethyloxazoline

PMOXA-PDMS-PMOXA
Type Polymer
Formula
Role layer
2

doxorubicin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role dopant

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
compression isotherm

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
RAW 264.7 murine macrophage cell line

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
  1. ZY6MgtufroKfBJrmtP
Product

polymethyloxazoline-polydimethylsiloxane nanomembrane

Interlayer spacing: 4 nm

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • doxorubicin
  1. WWK75zKRZiUEBCVn
Product

polymethyloxazoline-polydimethylsiloxane nanomembrane

Interlayer spacing: 4 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial